SNP ID | Position | Alleles | Trait | Variation Type |
---|---|---|---|---|
rs74641711 | chr18:79727394 (GRCh38.p7) | C>T | opioid dependence | SNV(Single Nucleotide Variation) |
Gene Symbol | Pearson Correlation Coefficient |
---|---|
XAB2 | 0.869 |
KIAA2013 | 0.866 |
ADRM1 | 0.863 |
AP5Z1 | 0.857 |
E2F4 | 0.852 |
SPNS1 | 0.846 |
ZGPAT | 0.846 |
DRG2 | 0.841 |
E4F1 | 0.84 |
HM13 | 0.836 |
Gene Symbol | Pearson Correlation Coefficient |
---|---|
OR4F5 | -0.584 |
OR4F29 | -0.541 |
MTRNR2L9 | -0.389 |
MTRNR2L6 | -0.361 |
MTRNR2L10 | -0.32 |
MTRNR2L1 | -0.276 |
OR4F16 | -0.268 |
MTRNR2L2 | -0.251 |
SFTA2 | -0.238 |
USP17L4 | -0.238 |
ID | Drug Name | Action | PubMed |
---|---|---|---|
C016403 | 2,4-dinitrotoluene | "2,4-dinitrotoluene affects the expression of CTDP1 mRNA" | 21346803 |
D000082 | Acetaminophen | Acetaminophen results in decreased expression of CTDP1 mRNA | 22230336 |
D000082 | Acetaminophen | Acetaminophen affects the expression of CTDP1 mRNA | 17562736 |
D020106 | Acrylamide | Acrylamide results in increased expression of CTDP1 mRNA | 28959563 |
D016604 | Aflatoxin B1 | Aflatoxin B1 results in increased methylation of CTDP1 gene | 27153756 |
D016604 | Aflatoxin B1 | Aflatoxin B1 results in increased expression of CTDP1 mRNA | 19770486 |
D000535 | Aluminum | [APP protein modified form binds to Aluminum] which results in decreased expression of CTDP1 mRNA | 21298039 |
D001151 | Arsenic | Arsenic affects the methylation of CTDP1 gene | 25304211 |
D001280 | Atrazine | Atrazine results in increased expression of CTDP1 mRNA | 25929836 |
D001564 | Benzo(a)pyrene | Benzo(a)pyrene results in increased expression of CTDP1 mRNA | 22228805 |
C006780 | bisphenol A | bisphenol A results in decreased expression of CTDP1 mRNA | 25181051 |
D019256 | Cadmium Chloride | Cadmium Chloride results in increased expression of CTDP1 mRNA | 19010381 |
D002251 | Carbon Tetrachloride | Carbon Tetrachloride results in decreased expression of CTDP1 mRNA | 17484886 |
C059262 | cidofovir | cidofovir results in decreased expression of CTDP1 mRNA | 25596134 |
C012843 | cinnamic aldehyde | cinnamic aldehyde results in increased expression of CTDP1 mRNA | 20008804 |
D004002 | Clodronic Acid | Clodronic Acid results in decreased expression of CTDP1 mRNA | 25596134 |
C018021 | cobaltous chloride | cobaltous chloride results in increased expression of CTDP1 mRNA | 19320972 |
C018021 | cobaltous chloride | cobaltous chloride results in increased expression of CTDP1 mRNA | 24386269 |
D002945 | Cisplatin | Cisplatin results in decreased expression of CTDP1 mRNA | 25596134 |
D004997 | Ethinyl Estradiol | Ethinyl Estradiol results in increased expression of CTDP1 mRNA | 17942748 |
D004997 | Ethinyl Estradiol | [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of CTDP1 mRNA | 17942748 |
D006861 | Hydrogen Peroxide | Hydrogen Peroxide results in decreased expression of CTDP1 mRNA | 18951874 |
D007069 | Ifosfamide | Ifosfamide results in decreased expression of CTDP1 mRNA | 25596134 |
D008687 | Metformin | Metformin results in increased expression of CTDP1 mRNA | 25596134 |
D008741 | Methyl Methanesulfonate | Methyl Methanesulfonate results in decreased expression of CTDP1 mRNA | 26011545 |
C044387 | N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine | "N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine results in decreased expression of CTDP1 mRNA" | 12756304 |
D010100 | Oxygen | Oxygen deficiency results in decreased expression of CTDP1 mRNA | 25596134 |
C006253 | pirinixic acid | [pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of CTDP1 mRNA | 19710929 |
D012999 | Soman | Soman results in increased expression of CTDP1 mRNA | 19281266 |
C004648 | testosterone enanthate | testosterone enanthate affects the expression of CTDP1 mRNA | 17440010 |
D013749 | Tetrachlorodibenzodioxin | Tetrachlorodibenzodioxin affects the expression of CTDP1 mRNA | 21570461 |
D013749 | Tetrachlorodibenzodioxin | [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of CTDP1 mRNA | 17942748 |
D014241 | Trichloroethylene | Trichloroethylene results in increased methylation of CTDP1 gene | 27618143 |
C057693 | troglitazone | troglitazone results in decreased expression of CTDP1 mRNA | 28973697 |
D001335 | Vehicle Emissions | Vehicle Emissions affects the methylation of CTDP1 gene | 25560391 |
GO ID | GO Term | Qualifier | Evidence | PubMed |
---|---|---|---|---|
GO:0001096 | TFIIF-class transcription factor binding | - | IPI | 12732728 15723517 |
GO:0004721 | phosphoprotein phosphatase activity | - | TAS | - |
GO:0005515 | protein binding | - | IPI | 9765293 15670829 |
GO:0008420 | CTD phosphatase activity | - | IBA | 21873635 |
GO:0008420 | CTD phosphatase activity | - | IDA | 9765293 12721286 |
GO:0030957 | Tat protein binding | - | IPI | 15723517 |
GO ID | GO Term | Qualifier | Evidence | PubMed |
---|---|---|---|---|
GO:0006366 | transcription by RNA polymerase II | - | TAS | - |
GO:0006368 | transcription elongation from RNA polymerase II promoter | - | TAS | - |
GO:0006470 | protein dephosphorylation | - | IDA | 9765293 22692537 |
GO:0010458 | exit from mitosis | - | IMP | 22692537 |
GO:0043923 | positive regulation by host of viral transcription | - | IDA | 15723517 |
GO:0051301 | cell division | - | IEA | - |
GO:0061052 | negative regulation of cell growth involved in cardiac muscle cell development | - | IEA | - |
GO:0070940 | dephosphorylation of RNA polymerase II C-terminal domain | - | IBA | 21873635 |
GO ID | GO Term | Qualifier | Evidence | PubMed |
---|---|---|---|---|
GO:0000922 | spindle pole | - | IDA | 22692537 |
GO:0005634 | nucleus | - | IDA | 15723517 |
GO:0005654 | nucleoplasm | - | IDA | - |
GO:0005654 | nucleoplasm | - | TAS | - |
GO:0005737 | cytoplasm | - | IEA | - |
GO:0005813 | centrosome | - | IDA | 22692537 |
GO:0005819 | spindle | - | IDA | 22692537 |
GO:0016591 | DNA-directed RNA polymerase II, holoenzyme | - | IBA | 21873635 |
GO:0030496 | midbody | - | IDA | 22692537 |
GO:0032991 | protein-containing complex | - | IMP | 12732728 |
GO:0043231 | intracellular membrane-bounded organelle | - | IDA | - |
GO:0051233 | spindle midzone | - | IDA | 22692537 |
KEGG ID | KEGG Term |
---|
Reactome ID | Reactome Term | Evidence |
---|---|---|
R-HSA-112382 | Formation of RNA Pol II elongation complex | TAS |
R-HSA-113418 | Formation of the Early Elongation Complex | TAS |
R-HSA-162587 | HIV Life Cycle | IEA |
R-HSA-162587 | HIV Life Cycle | TAS |
R-HSA-162599 | Late Phase of HIV Life Cycle | IEA |
R-HSA-162599 | Late Phase of HIV Life Cycle | TAS |
R-HSA-162906 | HIV Infection | IEA |
R-HSA-162906 | HIV Infection | TAS |
R-HSA-1643685 | Disease | IEA |
R-HSA-1643685 | Disease | TAS |
R-HSA-167152 | Formation of HIV elongation complex in the absence of HIV Tat | IEA |
R-HSA-167158 | Formation of the HIV-1 Early Elongation Complex | IEA |
R-HSA-167169 | HIV Transcription Elongation | IEA |
R-HSA-167169 | HIV Transcription Elongation | TAS |
R-HSA-167172 | Transcription of the HIV genome | IEA |
R-HSA-167172 | Transcription of the HIV genome | TAS |
R-HSA-167200 | Formation of HIV-1 elongation complex containing HIV-1 Tat | IEA |
R-HSA-167200 | Formation of HIV-1 elongation complex containing HIV-1 Tat | TAS |
R-HSA-167238 | Pausing and recovery of Tat-mediated HIV elongation | IEA |
R-HSA-167242 | Abortive elongation of HIV-1 transcript in the absence of Tat | IEA |
R-HSA-167243 | Tat-mediated HIV elongation arrest and recovery | IEA |
R-HSA-167246 | Tat-mediated elongation of the HIV-1 transcript | IEA |
R-HSA-167246 | Tat-mediated elongation of the HIV-1 transcript | TAS |
R-HSA-167287 | HIV elongation arrest and recovery | IEA |
R-HSA-167290 | Pausing and recovery of HIV elongation | IEA |
R-HSA-212436 | Generic Transcription Pathway | TAS |
R-HSA-3700989 | Transcriptional Regulation by TP53 | TAS |
R-HSA-5663205 | Infectious disease | IEA |
R-HSA-5663205 | Infectious disease | TAS |
R-HSA-674695 | RNA Polymerase II Pre-transcription Events | TAS |
R-HSA-6796648 | TP53 Regulates Transcription of DNA Repair Genes | TAS |
R-HSA-73857 | RNA Polymerase II Transcription | TAS |
R-HSA-74160 | Gene expression (Transcription) | TAS |
R-HSA-75955 | RNA Polymerase II Transcription Elongation | TAS |
PMID | Title (Year) | Author | Journal |
---|